The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Galectin-9 as a regulator of immune interactions in the tumor microenvironment and novel therapeutic target in biliary tract cancer.
 
Emilie AK Warren
No Relationships to Disclose
 
Jacklyn Hammons
No Relationships to Disclose
 
Jessica M. Keilson
No Relationships to Disclose
 
Megan Wyatt
Patents, Royalties, Other Intellectual Property - Pending Patent PCT/US2022/051528: Ex Vivo Cytokine Priming Strategies For Preparing Activated CD26-High Immune Cells And Uses In Cancer Therapies
 
Caroline Medin
No Relationships to Disclose
 
Curtis Henry
No Relationships to Disclose
 
Sarah Kulkarni
No Relationships to Disclose
 
Yuan Liu
No Relationships to Disclose
 
Brian Robinson
No Relationships to Disclose
 
Alyssa Krasinskas
No Relationships to Disclose
 
Shishir K. Maithel
Consulting or Advisory Role - AstraZeneca
Research Funding - Celgene
 
Chrystal M Paulos
Leadership - Ares Immunotherapy
Stock and Other Ownership Interests - Ares Immunotherapy
Consulting or Advisory Role - Ares Immunotherapy
Research Funding - Biolocity
Patents, Royalties, Other Intellectual Property - We have patents and patents pending
(OPTIONAL) Uncompensated Relationships - Ares Immunotherapy
 
Gregory B. Lesinski
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Vaccinex (Inst)